Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone + Maintenance Therapy in Peritoneal Metastatic Colorectal Cancer
NCT07405736Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of cobiprostone in colorectal cancer (CRC), peritoneal metastasis (PM), sponsored by Sun Yat-sen University. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
cobiprostone
03
Conditions
colorectal cancer (CRC)peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT07405736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07405736.